Polyglutamine spinocerebellar ataxias: emerging therapeutic targets
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2020.1827394
Abstract: ABSTRACT Introduction Six of the most frequent dominantly inherited spinocerebellar ataxias (SCAs) worldwide – SCA1, SCA2, SCA3, SCA6, SCA7, and SCA17 – are caused by an expansion of a polyglutamine (polyQ) tract in the corresponding… read more here.
Keywords: targets polyglutamine; emerging therapeutic; polyglutamine spinocerebellar; therapeutic targets ... See more keywords